MedPage Today on MSN
Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer
U.S. study supports findings from a global trial using an external control arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results